{"id":16896,"date":"2010-09-10T14:08:09","date_gmt":"2010-09-10T18:08:09","guid":{"rendered":"http:\/\/piel-l.org\/blog\/?p=16896"},"modified":"2010-09-10T14:08:09","modified_gmt":"2010-09-10T18:08:09","slug":"articulos-cientificos-edicion-276","status":"publish","type":"post","link":"https:\/\/piel-l.org\/blog\/16896","title":{"rendered":"Art\u00edculos Cient\u00edficos Edicion 276"},"content":{"rendered":"<ul>\n<li><a href=\"http:\/\/piel-l.org\/blog\/wp-content\/uploads\/\/2010\/09\/Interventionsformelasma.pdf\" target=\"_blank\">\u00bfCu\u00e1les son las intervenciones m\u00e1s efectivas para el tratamiento del melasma?<\/a>.\u00a0Interventions for melasma. Cochrane Database of Systematic Reviews 2010; N\u00b07: CD003583.<\/li>\n<li><a href=\"http:\/\/piel-l.org\/blog\/wp-content\/uploads\/\/2010\/09\/Melanoma_New_England_Journal_of_Medicine_2010_363_8_-_7111.pdf\" target=\"_blank\">Inhibition of Mutated, Activated BRAF in Metastatic Melanoma<\/a>. The New England Journal of Medicine. \u00ab<em><span style=\"font-size: x-small;\">The identification of somatic mutations in the gene encoding the serine\u2013threonine protein kinase B-RAF (BRAF) in the majority of melanomas offers an opportunity to test oncogene-targeted therapy for this disease<\/span><\/em>\u00ab<\/li>\n<li><a href=\"http:\/\/piel-l.org\/blog\/wp-content\/uploads\/\/2010\/09\/Lupus-monitoreo.pdf\" target=\"_blank\">Recomendaciones para el monitoreo de pacientes con lupus eritematoso sist\u00e9mico en la pr\u00e1ctica cl\u00ednica y en estudios observacionale<\/a>s. European League Against Rheumatism (EULAR). Annals of the Rheumatic Diseases 2010; 69(7): 1269-74. <span style=\"font-size: x-small;\"><em>\u00abLos criterios y par\u00e1metros que deben aplicarse para monitorear la evoluci\u00f3n de los pacientes afectados por una determinada patolog\u00eda requieren de una estandarizaci\u00f3n que permita una confiable evaluaci\u00f3n y la posibilidad de comparar lo ocurrido en otros ambientes asistenciales. En este sentido, la mencionada sociedad elabor\u00f3, sobre la base de las evidencias cient\u00edficas disponibles, recomendaciones para el seguimiento de los pacientes con lupus eritematoso sist\u00e9mico\u00bb<\/em><\/span>.<\/li>\n<\/ul>\n","protected":false},"excerpt":{"rendered":"<p>\u00bfCu\u00e1les son las intervenciones m\u00e1s efectivas para el tratamiento del melasma?.\u00a0Interventions for melasma. Cochrane Database of Systematic Reviews 2010; N\u00b07: CD003583. Inhibition of Mutated, Activated BRAF in Metastatic Melanoma. The New England Journal of Medicine. \u00abThe identification of somatic mutations in the gene encoding the serine\u2013threonine protein kinase B-RAF (BRAF) in the majority of melanomas &hellip;<\/p>\n","protected":false},"author":16,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[8],"tags":[],"class_list":["post-16896","post","type-post","status-publish","format-standard","","category-articulos-cientificos"],"_links":{"self":[{"href":"https:\/\/piel-l.org\/blog\/wp-json\/wp\/v2\/posts\/16896","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/piel-l.org\/blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/piel-l.org\/blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/piel-l.org\/blog\/wp-json\/wp\/v2\/users\/16"}],"replies":[{"embeddable":true,"href":"https:\/\/piel-l.org\/blog\/wp-json\/wp\/v2\/comments?post=16896"}],"version-history":[{"count":0,"href":"https:\/\/piel-l.org\/blog\/wp-json\/wp\/v2\/posts\/16896\/revisions"}],"wp:attachment":[{"href":"https:\/\/piel-l.org\/blog\/wp-json\/wp\/v2\/media?parent=16896"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/piel-l.org\/blog\/wp-json\/wp\/v2\/categories?post=16896"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/piel-l.org\/blog\/wp-json\/wp\/v2\/tags?post=16896"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}